Biocon Biologics ties-up with Sandoz Australia for cancer biosimilars
Sandoz will get the exclusive rights to promote, sell, and distribute Trastuzumab and Bevacizumab, which are used in the treatment of various cancers, in Australia
Source: moneycontrol.com